跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
G-Rb1
首页
药物
G-Rb1
G-Rb1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Heteroarylpiperidine and piperazine derivatives as fungicides
US 9375009 B2
申请人: BAYER IP GMBH
优先权: 2011
CN
US
5 件公开
GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES
US 2014275179 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2014
CN
US
2 件公开
USE OF THE RB1, GINSENOSIDE FOR STIMULATING ELASTIN SYNTHESIS
US 2002015743 A1
申请人: MEYBECK ALAIN
优先权: 1997
US
Compound red sage root freezing-dried powder injection
CN 101084998 B
申请人: TIANJIN TASLY ZHIJIAO PHARM CO
优先权: 2006
CN
Compound red sage root freezing-dried powder injection containing notoginseng and its preparation method
CN 101084999 B
申请人: TIANJIN TASLY ZHIJIAO PHARM CO
优先权: 2006
CN
Ginsenoside composition
CN 105073122 A
申请人: KIM S KOREAN GINSENG CO LTD
优先权: 2013
CN
Prepared radix notoginseng extract and preparing method and application thereof
CN 110151807 A
申请人: UNIV KUNMING SCIENCE & TECHNOLOGY
优先权: 2018
CN
Reagent for enabling bone mesenchymal stem cells (BMSCs) to target at myocardial infarction lesions and preparation method
CN 112402457 A
申请人: CHANGZHOU NO 2 PEOPLES HOSPITAL
优先权: 2020
CN
Sterilization process of pseudo-ginseng medicinal material
CN 113318138 A
申请人: LANZHOU INST OF FOOD AND DRUG INSPECTION AND TESTING
优先权: 2021
CN
Qi-tonifying and blood-activating ointment and preparation method thereof
CN 114272324 A
申请人: JIANGSU SEVEN ROOT NATURAL PHARMACEUTICAL LTD COMPANY
优先权: 2021
CN
第 1 / 2 页
上一页
下一页
药物
反馈